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Abstract
Aims: To compare falls sustained in two groups of patients (one with mental disorders and the other
neurocognitive disorders), in two acute inpatient older adult mental health services in Western Australia (WA).
Background: Falls are the most common adverse event experienced during inpatient care. Older people with
mental disorders and neurocognitive disorders constitute a high-risk group for accidental falls in hospitals.
Methods: Data relating to 207 fall events from 2010-2011 reported in medical records and incident reports were
collected. Individuals who sustained a fall were grouped as having a mental disorder (n=73) or neurocognitive
disorder (n=134) according to their primary ICD10 diagnosis.
Results: Significant differences in the factors that contributed to the fall between the two groups were highlighted.
Falls sustained by those with a neurocognitive disorder were due to confusion and disorientation, and psychotropic
medication effects. Their falls were more likely to be unwitnessed and injuries were generally less severe. Falls
sustained by older adults with mental disorders were attributed to symptoms of their illness or medication side
effects and tended to result in more severe injuries requiring medical treatment or further investigation.
Conclusions: Older adults with neurocognitive disorders and behavioural and psychological symptoms
associated to dementia have different falls risk factors related to their specific illness and cognitive functioning.
There is a need for health professionals to receive training to assess, manage and provide appropriate interventions
to reduce the specific falls risks in patients with both mental disorders and neurocognitive disorders.
Keywords: Falls; Functional disorder; Organic disorder; Older adult
mental health services; Mental health nursing
Introduction
It is anticipated that by the year 2030, 20% of the Australian
population will be aged over 65 years [1]. As the population of
Australia ages the number of older adults living with a mental disorder
will also increase [2]. Older people with an enduring and/or episodic
severe mental disorder during adulthood will ‘graduate’ from
requiring services designed to meet the needs of adults of working age
(adult mental health services) to requiring services designed for older
people, 65 years and older (older adult mental health services or
residential care) [3]. Providing acute mental health services to older
adults in Australia will become more complex as older people with
mental disorders are more likely to have multiple physical health
conditions and cognitive impairments [4].
Acute inpatient older adult mental health services (OAMHS) in
Australia are generally small services attached to inpatient facilities
that also provide mental health care to adults aged between 18-65
years [5]. These services provide specialist care for older adults with
severe psychosis or depression, chronic schizophrenia or patients with
neurocognitive disorders such as delirium or dementia who are
agitated/psychotic [6,7]. This patient diagnostic mix reflects what has
been reported internationally [5]. It is estimated that up to 90% of all
patients with dementia will develop at least one episode of Behavioural
and Psychological Symptoms of Dementia (BPSD) that require
specialist care [8]. This Australia this specialist care is often provided
by acute inpatient mental health services. Acute OAMHS therefore are
tasked with the need to provide specialist interventions aimed at
relapse prevention and recovery to treat mental disorders as well as
providing assessment, supervision and assistance with activities of
daily living and supportive care for patients with neurocognitive
disorders and BPSD. Added to this is the everyday challenge to reduce
the potential for hospital acquired harms associated with delivering
acute inpatient services to older adults; for example infections,
decubitus ulcers, unwanted medication effects and injuries associated
with falls [9].
A fall is any unexplained event that results in the patient’s
inadvertently coming to rest on the floor, ground, or lower level [10].
Falls impose a substantial burden on health services in Australia and
contribute significant costs to an already over stretched health budget
[9]. Factors associated with falls include but are not limited to
cognitive impairment, gait disturbance and medications side effects.
The ability to stand from a sitting position, previous falls, needing
assistance with ambulation and hyperactive symptoms were the factors
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most strongly associated with falls in older adults in community
settings [11]. Although the majority of falls in older adults occur in the
community, falls are the most common adverse event experienced
during inpatient care and cognitively impaired older people constitute
a high-risk group for accidental falls in hospitals [12]. In 2010-11, 1.3
million patient days (or one in every 10 days spent in hospital) by a
person aged 65 and older was directly attributable to an injurious fall.
Fall rates for inpatient psychiatric services can be three to four times
higher than rates in general hospitals [13].
There are only a small number of studies that investigate falls in
hospitalised older adults with mental disorders. These studies have
highlighted that falls are more likely to occur in females, those who are
treated with electroconvulsive therapy (ECT), mood stabilizers [14],
benzodiazepine or antihypertensive medications or patients who have
more comorbid acute medical conditions [15] such as cardiac
arrhythmias, Parkinson's syndrome or dementias [14]. Added to these
are the complex issues relating to the mental disorder itself; altered
perceptual perception, the fluctuating nature of psychosis or
alterations in activity due to changes in mood state [7].
Aims
The aim of the study was to compare falls sustained in two groups
of patients (one with mental disorders and the other neurocognitive
disorders [16]) in two acute inpatient older adult mental health
services in Western Australia (WA).
Design
This study uses a between-group design.
Data Collection
Data relating to fall events reported in medical records and through
the Australian Incident Management System (AIMS) (N=207) were
collected from two OAMHS in Perth in 2010 and 2011.
Statistical analyses
All data was entered into a IBM SPSS Statistics 22 package (IBM
Software Group, 2013; Chicago, USA) [17]. Descriptive statistics and
Mann-Whitney U analysis were used to compare gender, age, ICD10
diagnoses, length of stay and co-morbidities (additional ICD10 codes).
Chi square analyses were used to determine between group differences
in factors that related to fall events and medications taken in the 24
hours prior to a fall.
Participants
Individuals who sustained a fall were grouped into having either a
neurocognitive disorder (n=134, 64.7%) or a mental disorder (n=73,
35.3%) according to the primary ICD10 diagnosis as recorded in their
medical record [16,18]. Neurocognitive disorders included ICD10
codes F00-09, G20-29 (diseases of the CNS) and G30-39 (degenerative
disorder of CNS). Mental disorders included F10-19 (substance use
disorders), F20-29 (schizophrenia and delusional disorders) and
F30-39 (affective disorders). There were six instances of injury and
poisoning (ICD-10 codes of S00-T98) where a review of the medical
record revealed that the injury or poisoning was self-inflicted in the
context of mood disorder so these were classified as mental disorders
(Table 1).
ICD10 code n %
Neurocognitive Disorders















G20-29 Diseases of the CNS 9 4.3
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F10-19 Substance use disorders 7 3.4
F10.7 1
F11.0 6

























Table 1: Primary ICD10 diagnosis
Ethical considerations
Permission to undertake the study was granted by the two OAMHS
involved in the study and ethical clearance to conduct the study was
obtained by the South Metropolitan Health Service Human Research
Ethics Committees (clearance number 12/6). Data collection involved
medical record review and obtaining fall event data from an incident
management data base so the need to gain participant consent was
waived. All data was de-identified.
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Results
Demographics
In patients who fell, there were significant gender differences
between the two groups with females with a mental disorder (n=49,
53.8%) outnumbering males (n=42, 46.2%) and males (n=85, 73.3%)
outnumbering females (n=31, 26.7%) neurocognitive disorders;
X2=8.433 (df, 1)=p 0.004. Fallers in the neurocognitive disorder group
tended to be older (M=77.3 years, SD=9.3 and range 52-96 years) than
those in the mental disorders group (M=76.1 years, SD=8.5 and range
60-91 years; X2=92.405 (df, 37)=p<0.001), tended to stay in hospital
longer (M=97.3 days, SD=91.3 and range 1-485 days compared to
M=51.5 days, SD=39.4 and range 1-230 days) Z=-3.615, p<0.001
(Mann-Whitney U) and have more comorbidities (M=9.9, SD=4.9,
range 1-19, compared with M=7.7, SD=3.5, range 0-18) Z=2.963,
p=0.003 (Mann-Whitney U). There were no between group






N % n % n % X2 df p
Gender
116 56.0 Male 85 64.9 31 42.5
91 44.0 Female 49 37.4 42 57.5 8.433 1 0.004*
Age
8 3.9 50-59 years 8 6.1 0 0.0
35 16.9 60-69 years 17 13.0 18 24.7
71 34.5 70-79 years 49 37.4 22 30.1
84 40.6 80-89 years 53 40.5 31 42.5
9 4.4 90-99 years 7 5.3 2 2.8 9.703 4 0.046*
Mental Health Act status
176 85.0 Voluntary 116 88.5 60 82.2
31 15.0 Involuntary 18 13.7 13 17.8 0.701 1 0.399
Length of stay
8 3.8 <2 weeks 3 2.3 5 6.8
19 9.2 2 weeks 13 9.9 6 8.2
28 13.5 3 weeks 12 9.2 16 21.9
95 45.9 1-3 months 55 42.0 40 54.8
31 15.0 3-6 months 29 22.1 2 2.7
26 12.6 >6 months 22 16.8 4 5.5 26.305 5 <0.001*
Co-morbidities
35 16.8 0 to 4 19 14.5 16 21.9
84 40.6 5 to 9 46 35.1 38 52.1
61 29.5 10 to 14 44 33.6 17 23.3
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Factors relating to the fall
There was a significant difference in the type of fall, activity prior to
a fall and the level of severity (determined by AIMS level) between the
two groups. Fallers with a neurocognitive disorder were likely to
sustain a fall from a standing position (n=57, 42.53%). Falls from
syncope were only experienced by those with a mental disorder (n=4,
5.5%). Fallers with neurocognitive disorder fell more frequently while
wandering, their falls were more likely to be unwitnessed and injuries
were generally less severe. There were no between group differences in
environmental influences such as trip/slip hazards, lighting, flooring
or the use of equipment (p>0.05).
Neurocognitive Disorders
(n=134)
Mental Disorders (n=73) X2 df p
Type of fall Unobserved 33 13
Chair to floor 18 7
Bed to floor 19 13
Slip/trip 7 8
From standing 57 28
Syncope 0 4 11.65 5 0.039*
Location of fall Unobserved 7 3
Bed area 52 36
Lounge/Dining room 31 9
Courtyard 10 5
Bathroom 9 8
Corridor 25 12 5.39 5 0.37







Resting/sleeping 16 10 16.36 5 0.006*
Witnesses Not witnessed 87 46
Nurse 44 20
Other 3 7 5.76 2 0.056#






9 4 3.73 4 0.44
Severity AIMS level 2& 3 16 7
AIMS Level 4 105 50
AIMS level 5 11 10
AIMS Level 6 2 6 7.78 3 0.05#
Totals 134 73
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* p<0.05, # Trend p<0.1
Table 3: Factors relating to the fall event
Factors relating to the patient
There were significant differences in patient related factors that
were reported as contributing to the falls. For fallers with
neurocognitive disorder, being confused or disorientated was likely to
be reported as being a causative factor in the fall (n=100, 74.6%).
Psychiatric symptoms were more likely reported as a contributor to
falls sustained by those in the mental disorders group, as were blood
pressure issues, urinary tract infection/incontinence issues, previous
mobility issues, falls history, obesity and inappropriate use of mobility






Confusion/disorientation 100 31 21.037 1 <0.001**
Psychiatric symptoms 7 11 5.768 1 0.016*
Orthostatic hypotension 5 11 8.516 1 0.004*
Medication effects 15 7 0.128 1 0.720
Urinary tract infection/incontinence 7 10 4.502 1 0.034*
Visual impairment 4 5 1.697 1 0.193
Foot wear 4 2 0.01 1 0.920
Sedation 15 3 2.987 1 0.084
Unsteady gait 47 17 3.074 1 0.080
Previous mobility issue 15 17 5.288 1 0.021*
Mechanical restraint 0 1 1.845 1 0.174
Inappropriate use of mobility aid 5 9 5.539 1 0.019*
Behavioural disturbance–intrusiveness 16 6 0.68 1 0.407
Fall history 5 10 6.985 1 0.008*
* p<0.05, ** p<0.01
Table 4: Patient related factors contributing to falls
Factors related to medications
There were a total of 151 different medications taken in the 24
hours prior to the fall. Most fallers took more than one prescribed
medication (M=6.42 medications, SD=3.64 and range 0-16). There was
no between group difference in the number of medications taken,
Z=-0.061, p=0.951 (Mann-Whitney U), but for 15 medications there
were significant between group differences observed in the frequency
of medications taken in more than 10 fall events (n=32), these are
listed in Table 5 below.





60 29.0 Paracetamol 44 16 3.400 1 0.183
58 28.0 Cholecalciferol 29 29 7.663 1 0.006**
52 25.1 Sodium Valproate 46 6 17.126 1 0.001**
50 24.2 Aspirin 26 24 2.683 1 0.03*
49 23.7 Metformin 42 7 20.601 1 0.001**
44 21.3 Lorazepam 37 7 9.239 1 0.01*
42 20.3 Coloxyl/Senna 18 24 11.047 1 0.001**
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42 20.3 Movicol 17 25 13.582 1 0.001**
38 18.4 Quetiapine 23 15 0.361 1 0.336
36 17.4 Mirtazapine 27 9 2.012 1 0.109
33 15.9 Risperidone 28 5 6.957 1 0.005**
31 15.0 Lactulose 25 6 4.043 1 0.032*
27 13.0 Atorvastatin 22 5 3.815 1 0.05*
24 11.6 Frusemide 19 5 2.477 1 0.086
22 10.6 Pantoprazole 17 5 1.695 1 0.143
21 10.1 Calcium Carbonate 17 4 2.693 1 0.101
21 10.1 Olanzapine 5 16 17.146 1 0.001**
20 9.7 Haloperidol 16 4 2.86 1 0.239
19 9.2 Esomeprazole 14 5 0.734 1 0.392
17 8.2 Sertraline 11 6 0 1 0.595
17 8.2 Thyroxine 8 9 2.535 1 0.094
16 7.7 Oxazepam 8 8 1.649 1 0.156
13 6.3 Clonazepam 13 0 7.557 1 0.023*
12 5.8 Gliclazide 11 1 4.047 1 0.037*
12 5.8 Citalopram 9 3 0.588 1 0.443
12 5.8 Metoprolol 7 5 0.229 1 0.423
12 5.8 Irbesartan 4 8 5.502 1 0.023*
11 5.3 Simvastatin 9 2 1.485 1 0.188
11 5.3 Thiamine 8 3 2.874 1 0.238
11 5.3 Mixtard 5 6 1.892 1 0.147
10 4.8 Diazepam 9 1 2.938 1 0.087
10 4.8 Escitalopram 8 2 1.073 1 0.300
10 4.8 Lithium 3 7 5.553 1 0.024*
* p≤0.05, ** p<0.01
Table 5 show medications that were taken by individuals within 24 hours of a fall.
Only medications that were taken on at least 10 occasions where a fall occurred are included.
CNS medications are in italics.
Table 5: Medications taken 24 hours prior to a fall event (n=207)
Discussion
In this study falls sustained by older adults admitted to two acute
OAMHS were investigated according to whether their primary
diagnosis was a mental or neurocognitive disorder. Neurocognitive
Disorders are classified in the Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-V) as disorders such as the
dementias, delirium, amnesic disorders and disorders previously
defined in the DSM-IV (Fourth Edition) [19] as ‘other cognitive
disorders’, where ‘cognitive deficits are the primary manifestation of
the disorder’ ([16], p591) Mental disorders in DSM-V include
disorders such as schizophrenia, depression and bipolar disorder
where although cognitive deficits are present they are not the primary
manifestations of the disorder [16,18]. Chapter five of the ICD-10 [20],
‘Mental and behavioural disorders-(F00-F99)’ include disorders of
psychological development with the exception being the disorders
listed (F00-F10) ‘neurocognitive, including symptomatic, mental
disorders’. The disorders covered in Chapter 6 ‘diseases of the nervous
system-(G00-G99)’ include inflammatory, systemic or degenerative
diseases of the central nervous system.
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Factors relating to falls
There were differences in the factors related to falls in the older
adult patients with neurocognitive and mental disorders in this study.
Patients with a mental disorder (affective disorders, schizophrenia and
delusional disorders or substance abuse disorders) were more likely to
sustain a fall due to symptoms of their mental disorder and side effects
from psychotropic medications (orthostatic hypotension). The injuries
sustained were more likely to require medical intervention or further
investigative procedures (AIMS level 5–Tables 3 and 4). Medication
effects, medical co morbidities and mental state issues such as
paranoid and unpredictable behaviour have been previously shown to
increase the risk of falls [7]. It is likely that older adults with mental
disorders are likely to have mild to moderate cognitive impairments
that put them at risk of falls due to altered executive functioning and
judgement rather than gait disturbance, confusion/disorientation and
the severe cognitive impairment seen in patients with a neurocognitive
disorder/dementia [21,22]. Changes in reaction time and coordination
that is often experienced with depression also increases fall risk, as it
can alter mobility and balance [23,24].
Confusion and disorientation were more commonly associated with
falls for those patients in this study with a neurocognitive disorder.
Confusion and disorientation related to dementia has been highlighted
to be an overwhelming cause for falls in many studies [12,25,26]. Some
suggest that cognitive impairment forms a continuum from mild to
severe [27,28] and that falls can be aligned to this trajectory [29-31].
Older adults who only sustained occasional falls may have subtle age-
related changes in the prefrontal cortex leading to failures of executive
control, whereas those older adults who were recurrent fallers may
have more advanced brain ageing that is associated with generalized
cognitive decline [32]. Better staffing levels, increased supervision,
diversional therapy and better training for patient care staff could
reduce the falls risk in this patient group [33].
Unwitnessed falls
In this study 87 (68%) of falls occurring in the neurocogntive group
were unwitnessed. In 34 (25%) of falls the patient was reported to be
wandering (mobilising with no purpose) and in 54 (40%) the reporter
did not know what the patient was doing directly prior to the fall.
Although the injuries sustained by this group of patients tended to be
less serious (AIMS level 4 or less suggesting need for medical review
and minor treatment such as suturing or dressing) this suggests a lack
or surveillance or supervision. Although close observation of patients,
particularly those prone to falling, goes a long way to preventing falls
[34] this should by no means be a “fix all” solution to falls
management. The use of untrained staff (sitters, attendants or
companions) with little understanding of neurocognitive or mental
disorders to supervise patients [35] is becoming common in OAMHS
to provide cost effective supervision of patients prone to falling. In
many instances untrained staff are unable to determine the difference
between BPSD and symptoms that indicate deteriorating mental state
in older adults with a mental disorder, so provide inappropriate or
inadequate care that may increase the risk of falling (for example
failing to recognise symptoms of psychosis that increase patient
agitation). Consistently, patient mix in existing services is an
important issue [36] and in older adult mental health services the
patients are admitted primarily by age rather than diagnosis with
mental and neurocognitive psychoses not differentiated. This reduces
the opportunity for nursing staff to develop interventions to reduce
the risk of falling for those patients with a mental disorder, as patients
with neurocognitive psychoses dominate staff time and resources [37].
Medication
The more medication taken by an older adult, the greater the risk of
falls, and in some instances medication is associated with the highest
frequency and severity of falls in an older adult mental health services
[13]. High rates of poly-pharmacology have been reported in
psychiatric hospitals [38]. Medication with strongest links to an
increased risk of falling includes serotonin reuptake inhibitors and
tricyclic antidepressants [39], antipsychotic agents [40],
benzodiazepines and anticonvulsants [25]. Many medications can
cause side effects such as hypotension/orthostatic hypotension,
extrapyramidal effects, slowed reactions, and symptoms like dizziness,
syncope, and weakness, which increases the risk for falls by affecting
gait, balance and mobility [41]. They may also cause sedation and
sensory disturbances that alter perception [42] and level or alertness
and anticholinergic effects that may contribute to risk of falls by
increasing the need for ambulation to meet toileting needs [43].
The use of medication is an important therapeutic measure in
treating mental disorders and BPSD. However psychotropic
medications are over prescribed in mental health settings [13,44] with
some suggesting there is little relationship between the type of
psychotropic drug prescribed and the symptoms for which it had been
dispensed [45,46]. Examining psychotropic medications associated
with falls in this study identified high use (more than five occasions) of
mood stabilisers (Sodium Valproate), benzodiazepines (Loarazepam,
Oxazepam, Clonazepam, and Diazepam), antipsychotic medications
(Queitapine, Risperidone, and Haloperidol) and antidepressants
(Mirtazapine), in the 24 hours prior to the fall in the absence of
diagnosed psychosis.
Interestingly the frequency of psychotropic medication prescribed
to older adults with purely a mental psychoses who fell was quite low
(n=89, 26.8%) compared with those in the neurocognitive group
(n=243, 75.2%). In these groups Risperidone was more commonly
taken by those who fell. Risperidone which is considered first line
management in agitated dementia with delusions [47] was the
antipsychotic of choice in this study with patients experiencing a
neurocognitive disorder. Although atypical antipsychotics were found
to be safe and efficacious in elderly mental health clients [48],
antipsychotics as a class of medication have been associated with the
greatest level of fall risk in both dementia specific and mental health
inpatient and community settings [42]. Long term use increases falls
risk however initiation has been associated with higher fracture rates
[40]. In an expert consensus guidelines series the recommendation was
an antipsychotic drug alone, for agitated dementia and a consideration
to adding a mood stabilizer [49].
Although there is some literature that suggests that Sodium
Valproate is helpful in treating BPSD [50], recent reviews question the
efficacy and tolerability of Sodium Valproate in BPSD [51].
Konovalov, Muralee [52] suggest that anticonvulsant mood stabilizers
should not be recommended for routine use in the treatment of BPSD
citing that of 7 RCTs of anticonvulsant therapy in BPSD published
only one showed significant improvement compared to placebo, while
five showed no statistical difference and one showed significant
worsening of BPSD in the treatment group compared to placebo.
Lonergan and Luxenberg [53] in their Cochrane systematic review
corroborated earlier findings that “valproate preparations are
ineffective in treating agitation among demented patients, and that
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valproate therapy is associated with an unacceptable rate of adverse
effects” p2. Although these prescribing practices are consistent with
current local prescribing practices for patients with BPSD [54], the
high incidence of falls associated with Sodium Valproate identified in
current data is concerning.
There is a fine line between appropriate medication management
and chemical/pharmacological restraint, especially in terms of
managing behaviour [55]. Australian national policy and local Mental
Health legislation compel clinicians to use the least restrictive
environment [56]. The use of mechanical and physical restraint within
the OAMHS is considered to contravene best practice principles
(mechanical restraint was associated with a patient fall on only one
occasion in this study) leaving medication as the most appropriate
option to manage behavioural disturbance. Generally the most
frequently prescribed medications for behavioural/psychological
problems are benzodiazepines [57] and this was the case in this
current study. Although many patients have reported the use of
medications (sedation) to be more acceptable than other measures of
restraint [58] one needs to consider the risk to benefit ratio of
administering medication that increases the risk of falling. In this
study, 22 falls were reported to be sustained as a direct consequence of
medication and a further 34 falls were attributed side effects of a
medication; 18 to sedation and 16 to orthostatic hypotension (Table
4). While the authors are not advocating the use of mechanical or
physical restraint, there is an urgent need to adopt more conservative
medication practices and more careful titration of medications that are
known to increase the risk of falling in OAMHS.
What was a pleasing finding was the number of medication to
reduce the harms associated with falls, for example Cholecalciferol
(Vitamin D3) which is associated with decreasing the risk of fractures
in elderly patients [59] and calcium supplements, were given routinely.
Although used primarily to treat cardiac co-morbidities a number of
patients who fell received Atorvastatin, Irbesartan or Simvastatin
(Table 5). Although available data regarding the use of Statins is mixed
there is some evidence to suggest that their use is associated with a
decreased risk of falling [60].
There were very few instances where agents to treat dementia such
as cholinesterase inhibitors (Donepezil, n=1) and Memantine (n=4)
were administered 24 hours prior to a fall. This is surprising given the
number of falls sustained by patients with a primarily neurocognitive
disorder. This may reflect infrequent use in the two OAMHS or that
these agents are not associated with falls as the effect that these agents
have on falls is not known [42].
Appropriate use of pharmacological agents is needed to treat older
patients with severe and enduring mental disorders and BPSD. There
is also a need for specialist trained staff to increase non-
pharmacological behavioural measures or interventions which can
provide training and promote psychological, social, environmental
and sensory interventions [44] for older adults admitted to OAMHS.
Improved assessment of falls risk on admission and appropriate
interventions and supervision are needed to reduce the risk of falls.
Increased surveillance, separating older adults in distinct cohorts
where those with mental disorders are managed separately from those
with a neurocognitive disorders, good medication management and
increasing funding for specialist equipment such as pressure alarms,
high-Low beds and hoists would reduce the risk of falls in OAMHS.
Conclusion
Older adults are at increased risk of sustaining a fall while admitted
to an inpatient OAMHS. In this study it was identified that older
adults with a mental disorder and older adults with BPSD have
different characteristics that put them at risk of falling. Older adults
with mental disorders are more at risk of falling due to factors related
to their mental disorder such as paranoia and depressive symptoms
and medication side effects and tend to suffer more severe injuries.
Those with a neurocognitive disorder are at risk of falling due to
confusion and disorientation and were more likely to be unwitnessed
or associated with wandering. This study highlights the need for health
professionals to receive appropriate training to assess and manage falls
risk in patients admitted to OAMHS and to be able to identify the
specific risks to each based on their medical diagnosis and level of
cognitive functioning.
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